Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy
Phase: PHASE2 | Sponsor: Kyle Greenway | Compound: Psilocybin
- Status
- planned
- Institution
- Kyle Greenway
- Start date
- 2026-01-01
- End date
- 2028-12-01
- Registry ID
- NCT07373535
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.